SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jubilant Ingrevia raises Rs 48 crore through Commercial Papers

27 Dec 2024 Evaluate

Jubilant Ingrevia has raised Rs 48 crore through Commercial Papers (‘CPs’) on December 27, 2024. Maturity of the said Commercial Papers will be on February 25, 2025. Tenure of the instrument is 60 days. 

The Finance Committee, at its meeting held on October 23, 2024 approved issuance of Commercial Papers up to an amount of Rs 600 crore outstanding at any point of time, in one or more tranches. The aggregate amount of Commercial Papers (including this issue) outstanding as on date is Rs 148 crore. 

Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.

Jubilant Ingrevia Share Price

683.00 23.60 (3.58%)
22-Apr-2026 11:49 View Price Chart
Peers
Company Name CMP
BASF India 3720.50
Tata Chemicals 707.90
SRF 2491.80
Pidilite Inds. 1403.00
Deepak Nitrite 1701.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×